Abstract 4039
Background
The aim of this study was to assess the prognostic significance of parameters derived from pretreatmentF-18 fluorodeoxyglucose positron emission tomography/computed tomography (F-18 FDG PET/CT) for patients with nasopharyngeal carcinoma (NPC) received intensity-modulated radiation therapy (IMRT). Furthermore, the functional information provided by PET/CT may offer the feasibility of biological conformality in tumor target delineation and dose planning.
Methods
We retrospectively reviewed 82 NPC patients who underwent pretreatment F-18 FDG PET/CT and received IMRT between 2010 and 2013. Maximum standardized uptake value (SUVmax) and metabolic tumor volume (MTV) of the primary tumor were measured by F-18 FDG PET/CT. MTV might be viewed as a collection of absolute SUV values equal to or greater than a certain threshold on each axial image of PET/CT. The ROC curve was used to determine the appropriate cut-off point of SUVmax and MTV. The prognostic significance of MTV, SUVmax was assessed in the study. Meanwhile, the paper studies the relation between SUVmax, MTV, and primary tumor volume (PTV). Receiver operating characteristic (ROC) analysis was used to determine the optimal MTV cut-off value.
Results
Positive correlations between PTV and MTV, SUVmax and MTV were found. PTV, SUVmax, and MTV were significant predictors of survival. The 3-year progression-free survival (PFS) for SUVmax≤8.20 and SUVmax>8.20 were 91.1% and 73.0% (p = 0.027). With furthermore analysis, patients having tumor with lower MTV had higher 3-year PFS than patients having tumor with higher MTV. The percentage of the MTV5.0 in PTV was 14.66±15.75% (95%CI,11.20-18.13).
Conclusions
Our study indicated that PET/CT-derived parameters, SUVmax and MTV, are very important in assessing prognosis and making radiotherapy planning. Patients having tumor with lower MTV had higher 3-year PFS than patients having tumor with higher MTV. It is necessary to give a more aggressive treatment for patients with higher MTV. The MTV5.0 might be an appropriate quantitative definition of hypoxic sub-volumes for radiotherapy boost to improve the therapeutic effect.
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1978 - FAM115c that upregulates proliferation and invasion under hypoxia could be a predictive biomarker for pancreatic cancer.
Presenter: Kiyoshi Saeki
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3682 - Pathologic assessment following neoadjuvant immunotherapy or chemotherapy demonstrates similar patterns in non-small cell lung cancer (NSCLC)
Presenter: Annikka Weissferdt
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3319 - Tumor-infiltrating CD3+ lymphocytes and ICOS+ T-cells predict a favorable survival in resected esophageal squamous cell carcinoma
Presenter: Min Hee Hong
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5130 - Chemokine receptor CXCR7 expression, function and clinical implications in head and neck squamous cell carcinoma
Presenter: Myung-Won Lee
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4483 - Assessment of PD-1/PD-L1 colocalization in hepatocellular carcinoma (HCC) using bright-field double labeling and quantitative digital image analysis
Presenter: Thomas Mrowiec
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1175 - Pulmonary tumor thrombotic microangiopathy (PTTM): 24 case series and its criteria for pathological diagnosis.
Presenter: Naoko Sato
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1359 - Autofluorescence: a new marker for identifying cancer stem cells (CSCs) in primary tumors
Presenter: Miriam López Gómez
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
2651 - NACC1 as a target of microRNA-331-3p regulates cell proliferation in urothelial carcinoma cells
Presenter: Kohei Morita
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
2233 - Somatic-stem transition of tumor cells is a key link in the metastasis
Presenter: Nicolai Litviakov
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
2601 - Profile of individuals who never undergo colorectal cancer screening
Presenter: Jérôme Viguier
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract